Table 31aVesco et al35: Sensitivity Analysis Showing Expected Colposcopies, Incremental Colposcopies, Life-Years, Incremental Life-Years, and Incremental Colposcopies per Life-Year for Strategies Identified as Efficient*

StrategyColposcopiesIncremental ColposcopiesLife Years (LYs)Incremental LYsICLY
No intervention069016.30
Cytology, q5, Age 2148348369182.25165.953
Cytology and HPV, q5, Age 3062614369218.1135.864
Cytology and HPV, q3, Age 3082519969233.8015.6913
Cytology and HPV, q2, Age 30112930469240.066.2649
Cytology and HPV, q1, Age 30148835969245.945.8861
Cytology, q1, Age 21193144369246.580.64692
*

Per 1,000 women. Women are assumed to begin screening at age 21 years. Screening intervals of every 1 (q1), 2 (q2), 3 (q3), and 5 (q5) years are compared.

From: Results

Cover of Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force
Screening for Cervical Cancer: A Decision Analysis for the U.S. Preventive Services Task Force [Internet].
Evidence Syntheses, No. 86s.
Kulasingam SL, Havrilesky L, Ghebre R, et al.

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.